COMP <GO>
PLRZ vs DRIO // EV/EBITDA & P/E VALUATION
Polyrizon Ltd. (NASDAQ) VS. DarioHealth Corp. (NASDAQ) • 15-METRIC TALLY: PLRZ 2
— DRIO 2
■ METRIC PARITY
LAST: $11.26 (+4.74%) • MKT CAP: $26.1M
valuation
—
LAST: $3.03 (+1.00%) • MKT CAP: $29.4M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PLRZ VS. DRIO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PLRZ | DRIO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 56.60% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -25.10% | -35.00% | +9.90 | PLRZ | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -20.74% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 5/9 | -4.00 | DRIO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.5 | 27.3 | +29.20 | PLRZ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $26.1M | $29.4M | -$3.3M | DRIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PLRZ REV | DRIO REV | PLRZ GROSS % | DRIO GROSS % | PLRZ FCF | DRIO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $17.5M | $22.4M | — | 56.6% | -$4.5M | -$26.1M |
| FY 2024 | $3.6M | $27.0M | — | 49.1% | -$1.1M | -$38.7M |
| FY 2023 | $1.8M | $157.3M | — | — | -$537.0K | -$30.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PLRZ // BETA —
DRIO // BETA —